Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

BHVN - Biohaven Ltd

Close
39.4
-0.410   -1.041%

Share volume: 853,091
Last Updated: Fri 30 Aug 2024 10:00:02 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 0.21%

PREVIOUS CLOSE
CHG
CHG%
$39.81
-0.41
-1.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 2022-03-31 2022-06-30
Fiscal Quarter Q1 2022 Q2 2022
Report Date 2022-05-10 2022-08-05
Total revenue 318.852 M 215.079 M
Cost of revenue 26.342 M 35.741 M
Gross profit 292.510 M 179.338 M
    -38.69%  
Operating expenses 346.342 M 468.935 M
Selling general and admin 227.243 M 250.455 M
Research and development 119.099 M 218.480 M
Total expenses 372.684 M 504.676 M
    35.42%  
Operating income -53.832 M -289.597 M
Ebit -53.832 M -289.597 M
Pretax income -92.594 M -441.801 M
    377.14%  
Income tax 24.303 M 84.000 K
Net income basic -209.072 M -441.387 M
    -111.12%  
Net income -209.072 M -441.387 M
    -111.12%